Stock DNA
Pharmaceuticals & Biotechnology
CNY 13,509 Million (Large Cap)
15.00
NA
5.59%
-0.34
22.88%
3.42
Revenue and Profits:
Net Sales:
942 Million
(Quarterly Results - Jun 2025)
Net Profit:
253 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.82%
0%
6.82%
6 Months
-1.53%
0%
-1.53%
1 Year
12.41%
0%
12.41%
2 Years
4.27%
0%
4.27%
3 Years
49.81%
0%
49.81%
4 Years
90.39%
0%
90.39%
5 Years
103.96%
0%
103.96%
Jiangzhong Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
12.39%
EBIT Growth (5y)
11.78%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.41
Sales to Capital Employed (avg)
1.05
Tax Ratio
15.82%
Dividend Payout Ratio
95.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
43.69%
ROE (avg)
16.29%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.42
EV to EBIT
12.82
EV to EBITDA
11.11
EV to Capital Employed
4.68
EV to Sales
2.80
PEG Ratio
1.20
Dividend Yield
5.59%
ROCE (Latest)
36.47%
ROE (Latest)
22.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
942.10
1,166.60
-19.24%
Operating Profit (PBDIT) excl Other Income
331.50
345.40
-4.02%
Interest
0.30
0.20
50.00%
Exceptional Items
0.60
0.00
Consolidate Net Profit
252.70
306.70
-17.61%
Operating Profit Margin (Excl OI)
312.60%
264.30%
4.83%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -19.24% vs -19.24% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -17.61% vs 73.67% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
4,371.20
4,489.70
-2.64%
Operating Profit (PBDIT) excl Other Income
1,035.00
966.00
7.14%
Interest
2.20
7.90
-72.15%
Exceptional Items
-5.80
-30.40
80.92%
Consolidate Net Profit
860.50
787.00
9.34%
Operating Profit Margin (Excl OI)
205.30%
186.90%
1.84%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -2.64% vs 17.37% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 9.34% vs 21.75% in Dec 2023
About Jiangzhong Pharmaceutical Co., Ltd. 
Jiangzhong Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






